Commerce Dashboard

Glenmark Pharmaceuticals

Go Back

Glenmark Pharmaceuticals

  • Leader in the discovery of new molecules
  • Ranked among the world's top 100 pharma and biotech companies
  • Employs over 10,000 people in over 80 countries
  • Among the top Indian pharmaceutical companies

Glenmark Pharmaceuticals Pvt Ltd is headquartered in Mumbai, India and was established in 1977. Today, it is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), and it currently has seven molecules in various stages of clinical development and pre-clinical development. The company has a significant presence in branded generics markets across emerging economies, including India. Its subsidiary, Glenmark Generics Ltd has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 10,400 people in over 80 countries. It has 14 manufacturing facilities in four countries and has six research and development (R&D) centres.


Glenmark Pharmaceuticals: Innovating Newer Molecules

2011 Wins Gold Patent Award in the categories of API Formulations and Export of Bulk Drugs by Pharmexcil
2010 Enters into exclusive licensing agreement with Par Pharmaceuticals
2008 Receives recognition by Forbes as one of the 'best under a billion dollar companies in Asia'
2007 Acquires Medicamenta, a marketing and manufacturing company in Czech Republic
2006 Signs out-licencing deal in discovery R&D with Merck KGaA, Germany
Research and Development
India is presently ranked 76th among a total of 143 economies, as per the Global Innovation Index (GII).